Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis — TESLA  

Lateral Amyotrophic Sclerosis Clinical Trial

Official title: Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Status Completed

Clinical Trial Summary

Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association.

Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Amyotrophic Lateral Sclerosis
• Lateral Amyotrophic Sclerosis
• Motor Neuron Disease
• Sclerosis
• Thromboembolism
• Venous Thrombo-embolic Desease

• NCT number: NCT04446325
• Study type: Observational
• Source: University Hospital, Brest
• Status: Completed
• Start date: March 1, 2020
• Completion date: May 1, 2020